Atlas Trials

Staccato Zaleplon Single Dose Pharmacokinetics

Clinical trial NCT00620620 · COMPLETED

Trial details

NCT number
NCT00620620
Sponsor
Alexza Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-02-01
Primary completion
2008-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.